What is more, our in vitro experiments showed that knockdown of CHRNB4 inhibited the growth of ESCC cells and the result of western blot validated that the potential mechanism was the Akt/mTOR and ERK1/2/mTOR signaling pathway, which play an essential role in ESCC progression. The gene discussed is MAPK3; the disease is esophageal squamous cell carcinoma.